BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38473723)

  • 1. The Effect of a Ketogenic Diet versus Mediterranean Diet on Clinical and Biochemical Markers of Inflammation in Patients with Obesity and Psoriatic Arthritis: A Randomized Crossover Trial.
    Lambadiari V; Katsimbri P; Kountouri A; Korakas E; Papathanasi A; Maratou E; Pavlidis G; Pliouta L; Ikonomidis I; Malisova S; Vlachos D; Papadavid E
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine profile characterization of naïve patients with psoriasis and psoriatic arthritis: implications for a pathogenic disease continuum.
    Ruscitti P; Esposito M; Di Cola I; Pellegrini C; De Berardinis A; Mastrangelo M; Gianneramo C; Barile A; Fargnoli MC; Cipriani P
    Front Immunol; 2023; 14():1229516. PubMed ID: 37520537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study.
    Caso F; Navarini L; Carubbi F; Picchianti-Diamanti A; Chimenti MS; Tasso M; Currado D; Ruscitti P; Ciccozzi M; Annarumma A; Laganà B; Perricone R; Afeltra A; Giacomelli R; Scarpa R; Costa L
    Rheumatol Int; 2020 Jun; 40(6):951-958. PubMed ID: 31605152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in oxylipin profile in psoriasis versus psoriatic arthritis.
    Coras R; Kavanaugh A; Kluzniak A; Holt D; Weilgosz A; Aaron A; Quehenberger O; Ritchlin C; Guma M
    Arthritis Res Ther; 2021 Jul; 23(1):200. PubMed ID: 34303373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guselkumab effectiveness and survival in patients with psoriasis and psoriatic arthritis: Multicenter analysis in daily clinical practice by the Spanish Psoriasis Group.
    Rocamora V; Crespi L; Ferran M; Llamas-Velasco M; Del Alcázar E; Carrascosa JM; Beltran E; Urruticoechea-Arana A; Estebaranz JLL; Vidal D; Riera J; Rodríguez L; Armesto S; Fernández JM; Aparicio G; Pérez S; Porcar S; Montesinos E; Gallardo F
    Dermatol Ther; 2022 Nov; 35(11):e15865. PubMed ID: 36175141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum interleukin-23 levels: relation to depression, anxiety, and disease activity in psoriatic arthritis patients.
    Tabra SA; Abd Elghany SE; Amer RA; Fouda MH; Abu-Zaid MH
    Clin Rheumatol; 2022 Nov; 41(11):3391-3399. PubMed ID: 35861930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with psoriatic arthritis have higher levels of FeNO than those with only psoriasis, which may reflect a higher prevalence of a subclinical respiratory involvement.
    Damiani G; Pacifico A; Rizzi M; Santus P; Bridgewood C; Bragazzi NL; Adawi M; Watad A
    Clin Rheumatol; 2020 Oct; 39(10):2981-2988. PubMed ID: 32240433
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Larid G; Delwail A; Dalle T; Vasseur P; Silvain C; Jégou JF; Morel F; Lecron JC; Gervais E
    Front Immunol; 2022; 13():993363. PubMed ID: 36426370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Composite Measures of Disease Activity in Psoriatic Arthritis: Comparative Instrument Performance Based on the Efficacy of Guselkumab in an Interventional Phase II Trial.
    Helliwell PS; Deodhar A; Gottlieb AB; Boehncke WH; Xu XL; Xu S; Wang Y; Hsia EC; Gladman DD; Ritchlin CT
    Arthritis Care Res (Hoboken); 2020 Nov; 72(11):1579-1588. PubMed ID: 31421033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broad proteomic screen reveals shared serum proteomic signature in patients with psoriatic arthritis and psoriasis without arthritis.
    Leijten E; Tao W; Pouw J; van Kempen T; Olde Nordkamp M; Balak D; Tekstra J; Muñoz-Elías E; DePrimo S; Drylewicz J; Pandit A; Boes M; Radstake T
    Rheumatology (Oxford); 2021 Feb; 60(2):751-761. PubMed ID: 32793974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visceral adiposity in patients with psoriatic arthritis and psoriasis alone and its relationship with metabolic and cardiovascular risk.
    Toussirot E; Aubin F; Desmarets M; Wendling D; Augé B; Gillard J; Messica O; Guillot X; Laheurte C; Monnet E; Dumoulin G
    Rheumatology (Oxford); 2021 Jun; 60(6):2816-2825. PubMed ID: 33232483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etanercept in Axial Spondyloarthritis, Psoriatic Arthritis, and Plaque Psoriasis: Real-World Outcome Data from German Non-interventional Study ADEQUATE.
    Feist E; Baraliakos X; Behrens F; Thaçi D; Plenske A; Klaus P; Meng T
    Rheumatol Ther; 2024 Apr; 11(2):331-348. PubMed ID: 38308727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of guselkumab on serum biomarkers in patients with active psoriatic arthritis and inadequate response to tumor necrosis factor inhibitors: results from the COSMOS phase 3b study.
    Schett G; Chen W; Gao S; Chakravarty SD; Shawi M; Lavie F; Zimmermann M; Sharaf M; Coates LC; Siebert S
    Arthritis Res Ther; 2023 Aug; 25(1):150. PubMed ID: 37587493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Twenty Days of the Ketogenic Diet on Metabolic and Respiratory Parameters in Healthy Subjects.
    Rubini A; Bosco G; Lodi A; Cenci L; Parmagnani A; Grimaldi K; Zhongjin Y; Paoli A
    Lung; 2015 Dec; 193(6):939-45. PubMed ID: 26410589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between body mass index, waist circumference and psoriatic arthritis in the Turkish population.
    Ozkaya DB; Onsun N; Topukçu B; Su O; Bahalı AG; Dizman D; Rezvani A; Uysal O
    Postepy Dermatol Alergol; 2016 Jun; 33(3):219-23. PubMed ID: 27512358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of obesity on quality of life, psychological status, and disease activity in psoriatic arthritis: a multi‑center study.
    Gok K; Nas K; Tekeoglu I; Sunar I; Keskin Y; Kilic E; Sargin B; Acer Kasman S; Alkan H; Sahin N; Cengiz G; Cuzdan N; Albayrak Gezer İ; Keskin D; Mulkoglu C; Resorlu H; Bal A; Duruoz MT; Kucukakkas O; Yurdakul OV; Alkan Melikoglu M; Aydin Y; Ayhan FF; Bodur H; Calis M; Capkin E; Devrimsel G; Ecesoy H; Hizmetli S; Kamanli A; Kutluk O; Sen N; Sendur OF; Tolu S; Toprak M; Tuncer T
    Rheumatol Int; 2022 Apr; 42(4):659-668. PubMed ID: 34453579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brodalumab, a human anti-interleukin-17-receptor antibody in the treatment of Japanese patients with moderate-to-severe plaque psoriasis: Efficacy and safety results from a phase II randomized controlled study.
    Nakagawa H; Niiro H; Ootaki K;
    J Dermatol Sci; 2016 Jan; 81(1):44-52. PubMed ID: 26547109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early diagnosis of psoriatic arthritis among psoriasis patients: clinical experience sharing.
    Su YJ
    Clin Rheumatol; 2020 Dec; 39(12):3677-3684. PubMed ID: 32468320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secukinumab Drug Survival in Psoriasis and Psoriatic Arthritis Patients: A 24-Month Real-Life Study.
    Ortolan A; Lorenzin M; Leo G; Pampaloni F; Messina F; Doria A; Piaserico S; Ramonda R
    Dermatology; 2022; 238(5):897-903. PubMed ID: 35263743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggressive weight-loss program with a ketogenic induction phase for the treatment of chronic plaque psoriasis: A proof-of-concept, single-arm, open-label clinical trial.
    Castaldo G; Rastrelli L; Galdo G; Molettieri P; Rotondi Aufiero F; Cereda E
    Nutrition; 2020 Jun; 74():110757. PubMed ID: 32222582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.